13.79
Overview
News
Price History
Option Chain
Why RDY Down?
Discussions
Forecast
Stock Split
Dividend History
Dr Reddys Laboratories Ltd Adr stock is traded at $13.79, with a volume of 1.94M.
It is down -1.50% in the last 24 hours and up +2.53% over the past month.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
See More
Previous Close:
$14.00
Open:
$13.74
24h Volume:
1.94M
Relative Volume:
0.99
Market Cap:
$2.30B
Revenue:
$3.47B
Net Income/Loss:
$668.83M
P/E Ratio:
3.4366
EPS:
4.0127
Net Cash Flow:
$253.46M
1W Performance:
+0.88%
1M Performance:
+2.53%
6M Performance:
-9.73%
1Y Performance:
-6.85%
Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile
Compare RDY with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
RDY
Dr Reddys Laboratories Ltd Adr
|
13.79 | 2.30B | 3.47B | 668.83M | 253.46M | 4.0127 |
![]()
ZTS
Zoetis Inc
|
153.47 | 65.50B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 46.99B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
HLN
Haleon Plc Adr
|
10.18 | 45.96B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
14.87 | 17.04B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
291.38 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-19-24 | Downgrade | Nomura | Buy → Neutral |
Jan-11-24 | Downgrade | Jefferies | Buy → Underperform |
Aug-29-23 | Downgrade | HSBC Securities | Buy → Hold |
May-18-23 | Downgrade | Bernstein | Outperform → Mkt Perform |
Mar-17-23 | Upgrade | BofA Securities | Neutral → Buy |
Jan-30-23 | Initiated | JP Morgan | Underweight |
Nov-14-22 | Downgrade | Credit Suisse | Neutral → Underperform |
Jan-03-22 | Resumed | BofA Securities | Neutral |
Jul-27-21 | Downgrade | Credit Suisse | Outperform → Neutral |
Feb-02-21 | Upgrade | Barclays | Equal Weight → Overweight |
Sep-18-20 | Upgrade | BofA Securities | Neutral → Buy |
Sep-18-20 | Upgrade | Investec | Sell → Hold |
Jan-28-20 | Downgrade | CLSA | Buy → Outperform |
Jan-27-20 | Downgrade | CLSA | Buy → Outperform |
Jan-09-20 | Upgrade | Citigroup | Sell → Buy |
Nov-04-19 | Downgrade | BofA/Merrill | Buy → Neutral |
Sep-04-19 | Upgrade | Credit Suisse | Underperform → Outperform |
Jul-01-19 | Upgrade | Macquarie | Neutral → Outperform |
Jun-20-19 | Initiated | Deutsche Bank | Hold |
Jun-11-19 | Initiated | Barclays | Equal Weight |
May-20-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Feb-19-19 | Upgrade | CLSA | Outperform → Buy |
Jan-17-19 | Downgrade | Citigroup | Neutral → Sell |
Sep-21-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Aug-31-17 | Upgrade | CLSA | Underperform → Outperform |
Jul-28-17 | Downgrade | CLSA | Underperform → Sell |
Jul-27-16 | Downgrade | HSBC Securities | Hold → Reduce |
Jul-27-16 | Downgrade | Jefferies | Hold → Underperform |
Feb-10-16 | Upgrade | Credit Agricole | Underperform → Buy |
Nov-10-15 | Downgrade | Citigroup | Buy → Neutral |
View All
Dr Reddys Laboratories Ltd Adr Stock (RDY) Latest News
Dr. Reddy’s Laboratories Ltd. ADR (RDY) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Asian ADRs See Mixed Results Despite Weekly Gains - Finimize
Dr. Reddy’s Looks Well Positioned for Long-Term Growth, Aided by Acquisitions and Partnerships - Morningstar
Investing in Dr. Reddy’s Laboratories Ltd. ADR (RDY): What You Must Know - knoxdaily.com
LLY Stock Quote Price and Forecast - CNN
NVO Stock Quote Price and Forecast - CNN
Zacks Industry Outlook Dr. Reddy's, Sandoz And Teva Pharmaceuticals - Barchart.com
Asian ADRs Climb, Showcasing North And South Asia Performances - Finimize
PDD Holdings Stock Delivers Phenomenal 5.82% Surge to $95.77 on April 14 – Bullish Momentum Lifts Chinese Tech - Hindustan Herald
3 Generic Drug Stocks To Watch Amid Trade War Jitters & Inflation Woes - Barchart.com
Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by Massachusetts Financial Services Co. MA - MarketBeat
Asian ADRs Shine As Zai Lab And CNFinance Lead The Gains - Finimize
Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - TradingView
Mixed Performance For Asian Stocks Traded On US Markets - Finimize
Grantham Mayo Van Otterloo & Co. LLC Has $5.67 Million Position in Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat
Asian Equities Traded in the US as American Depositary Receipts Tumble in Thursday Trading - TradingView
Pinpoint Asset Management Ltd Acquires 473,000 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat
Asian Equities Traded in the US as American Depositary Receipts Sharply Lower in Monday Trading - TradingView
Stocks to watch, April 7: IT, pharma, metals, oil-sensitive stocks, Nykaa, Dr Reddy's, Delhivery, Trent Ltd, and more - Upstox
Dr Reddy's gets over Rs 2,395 crore show cause notice from I-T authority - Moneycontrol
Asian Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Trending Lower in Wednesday Trading - TradingView
Generics Industry: India Celebrates Pharmaceutical Tariffs Exemption but Uncertainty Remains High - Morningstar
US Tariffs on Pharma: Zydus, Dr Reddy’s at highest risk, says Jefferies; Check impact on other Indian pharma stocks - Mint
Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by GQG Partners LLC - MarketBeat
American Healthcare REIT Inc (AHR) Stock: A Year of Decreases and Increases - The InvestChronicle
Asian Equities Traded in the US as ADRs Rise in Tuesday Trading - MSN
Asian Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - TradingView
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Asian Equities Traded in the US as American Depositary Receipts Lower in Friday Trading - TradingView
Infosys, Wipro, TCS, other IT stocks fall up to 3% after Accenture Q2 results. Details here - Mint
Infosys, Wipro ADRs drop over 3% on NYSE after Accenture hikes full-year revenue guidance to 5-7% on AI boom - Mint
Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Track Sharply Lower in Tuesday Trading - TradingView
FDA accepts Dr. Reddy’s biosimilar application for bone drugs By Investing.com - Investing.com India
Asian Equities Traded in the US as American Depositary Receipts Open Week Sharply Higher - TradingView
Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - GlobeNewswire Inc.
Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up 1.5% for Week - TradingView
Is TG Therapeutics Inc (NASDAQ: TGTX) A Good Investment For New Investors Now? - Stocks Register
Senores Pharmaceuticals to acquire 14 ANDAs from Dr Reddy's - Business Standard
Rhumbline Advisers Grows Position in Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat
Dr. Reddy's Laboratories Ltd. Sponsored ADR to Host Earnings Call - ACCESS Newswire
Stocks to watch: Bharti Airtel, Wipro, Coforge, Dr Reddy’s, Vakrangee among shares to remain in focus today - Mint
Dr Reddys Laboratories Ltd Adr Stock (RDY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):